Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

The cost effectiveness of early treatment with fluticasone propionate 250 microg twice a day in subjects with obstructive airway disease. Results of the DIMCA program.

van den Boom G, Rutten-van Mölken MP, Molema J, Tirimanna PR, van Weel C, van Schayck CP.

Am J Respir Crit Care Med. 2001 Dec 1;164(11):2057-66.

PMID:
11739135
2.

Underdiagnosis of asthma: is the doctor or the patient to blame? The DIMCA project.

van Schayck CP, van Der Heijden FM, van Den Boom G, Tirimanna PR, van Herwaarden CL.

Thorax. 2000 Jul;55(7):562-5.

3.

Active detection of chronic obstructive pulmonary disease and asthma in the general population. Results and economic consequences of the DIMCA program.

van den Boom G, van Schayck CP, van Möllen MP, Tirimanna PR, den Otter JJ, van Grunsven PM, Buitendijk MJ, van Herwaarden CL, van Weel C.

Am J Respir Crit Care Med. 1998 Dec;158(6):1730-8.

PMID:
9847260
4.

Association between health-related quality of life and consultation for respiratory symptoms: results from the DIMCA programme.

van den Boom G, Rutten-van Mölken MP, Tirimanna PR, van Schayck CP, Folgering H, van Weel C.

Eur Respir J. 1998 Jan;11(1):67-72.

5.

Prevalence of asthma and COPD in general practice in 1992: has it changed since 1977?

Tirimanna PR, van Schayck CP, den Otter JJ, van Weel C, van Herwaarden CL, van den Boom G, van Grunsven PM, van den Bosch WJ.

Br J Gen Pract. 1996 May;46(406):277-81.

6.

Evaluation of the suitability of weekly peak expiratory flow rate measurements in monitoring annual decline in lung function among patients with asthma and chronic bronchitis.

Tirimanna PR, Den Otter JJ, Van Schayck CP, Van Herwaarden CL, Folgering H, Van Weel C.

Br J Gen Pract. 1996 Jan;46(402):15-8.

Supplemental Content

Loading ...
Support Center